Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas
A multicenter Italian real-world study.
Sechi A, Rapparini L, Valtellini L, Pampaloni F, Cedirian S, Bruni F, Quadrelli F, Martelli G, Barbareschi M, Marzano AV, Piraccini BM, Starace M, Alopecia Areata Relapse Study Group
Journal of the American Academy of DermatologyIn the feed 13 Aug 2026, published online 13 Aug 2026, issue 2026 Aug 13, added to PubMed 13 Aug 2026
Topics: HairJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42595129 · DOI 10.1016/j.jaad.2026.08.031